Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$1.13B |
| 2 |
AT&T
T
|
+$275M |
| 3 |
Apple
AAPL
|
+$248M |
| 4 |
Walt Disney
DIS
|
+$235M |
| 5 |
Nike
NKE
|
+$195M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.4B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.17B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$863M |
| 4 |
Advanced Micro Devices
AMD
|
+$808M |
| 5 |
Amazon
AMZN
|
+$783M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.82% |
| 2 | Technology | 1.6% |
| 3 | Consumer Discretionary | 1.3% |
| 4 | Financials | 0.99% |
| 5 | Communication Services | 0.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ISEE
3676
CALL
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $5.05M | ﹤0.01% |
302,200
-365,600
| -55% | -$5.99M |
|
3677
First Trust Health Care AlphaDEX Fund
FXH
$1.15B
| $5.05M | ﹤0.01% |
+40,677
| New | +$4.87M |
|
3678
Royal Gold
RGLD
$22.3B
| $5.05M | ﹤0.01% |
47,995
-76,479
| -61% | -$7.71M |
|
3679
CALL
Direxion Daily FTSE China Bull 3X ETF
YINN
$670M
| $5.05M | ﹤0.01% |
30,315
+4,105
| +16% | +$849K |
|
3680
PUT
Jack in the Box
JACK
$311M
| $5.05M | ﹤0.01% |
57,700
-9,000
| -13% | -$836K |
|
3681
Reinsurance Group of America
RGA
$16B
| $5.04M | ﹤0.01% |
46,080
+5,544
| +14% | +$616K |
|
3682
PUT
Iovance Biotherapeutics
IOVA
$3.63B
| $5.04M | ﹤0.01% |
264,200
-51,800
| -16% | -$1.14M |
|
|
TBHC
3683
PUT
DELISTED
The Brand House Collective
TBHC
| $5.04M | ﹤0.01% |
337,800
-56,600
| -14% | -$1.17M |
|
|
GTLS
3684
CALL
DELISTED
Chart Industries
GTLS
| $5.04M | ﹤0.01% |
31,600
-10,100
| -24% | -$1.79M |
|
3685
CALL
Penumbra
PEN
$12.7B
| $5.03M | ﹤0.01% |
17,500
-30,700
| -64% | -$8.12M |
|
3686
FirstCash
FCFS
$9.51B
| $5.02M | ﹤0.01% |
+67,161
| New | +$5.16M |
|
3687
State Street Industrial Select Sector SPDR ETF
XLI
$32.9B
| $5.01M | ﹤0.01% |
47,385
-391,523
| -89% | -$40.7M |
|
|
LICY
3688
CALL
DELISTED
Li-Cycle Holdings Corp.
LICY
| $5.01M | ﹤0.01% |
62,913
-9,850
| -14% | -$930K |
|
3689
MaxLinear
MXL
$5.6B
| $5.01M | ﹤0.01% |
66,435
+54,736
| +468% | +$3.5M |
|
3690
PUT
CleanSpark
CLSK
$2.99B
| $5.01M | ﹤0.01% |
526,000
-17,700
| -3% | -$283K |
|
3691
Warrior Met Coal
HCC
$5.65B
| $5M | ﹤0.01% |
194,518
-107,014
| -35% | -$2.57M |
|
3692
PUT
Manchester United
MANU
$3.81B
| $5M | ﹤0.01% |
351,200
-313,500
| -47% | -$4.94M |
|
3693
CALL
PetMed Express
PETS
$40.8M
| $5M | ﹤0.01% |
198,000
-99,400
| -33% | -$2.75M |
|
|
SF
3694
CALL
Stifel
SF
$12.3B
| $5M | ﹤0.01% |
106,500
+29,550
| +38% | +$1.43M |
|
3695
AES
AES
$10.5B
| $5M | ﹤0.01% |
205,700
-184,031
| -47% | -$4.47M |
|
3696
PUT
Quince Therapeutics
QNCX
$34.3M
| $5M | ﹤0.01% |
1,980
-130
| -6% | -$793K |
|
3697
CALL
Weatherford International
WFRD
$6.72B
| $5M | ﹤0.01% |
180,200
+35,900
| +25% | +$984K |
|
3698
CALL
Herc Holdings
HRI
$5.03B
| $4.99M | ﹤0.01% |
31,900
-56,800
| -64% | -$10M |
|
3699
Microvision
MVIS
$56.3M
| $4.99M | ﹤0.01% |
66,430
-28,497
| -30% | -$3.4M |
|
3700
Bloomin' Brands
BLMN
$906M
| $4.99M | ﹤0.01% |
237,709
+137,776
| +138% | +$2.91M |
|
Similar funds
Jeff Yass's Q4 2021 Portfolio in Review
As of Q4 2021, Jeff Yass held 14,586 positions worth $667B, down 11% from $745B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Jeff Yass's Q4 2021 filing shows 1,953 new, 4,555 increased, 6,197 reduced and 1,571 closed positions. Its largest new stake was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.4B.
By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2021 buy was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M.
- Jeff Yass added most to Citigroup in Q4 2021, an estimated $1.13B increase.
- Jeff Yass's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.4B.
- Jeff Yass fully exited Stamps.com, Inc. in Q4 2021, selling an estimated $78.8M.
- Jeff Yass's ten largest holdings make up 32% of its $667B portfolio in Q4 2021.
- Jeff Yass opened 1,953 new positions and closed 1,571 in Q4 2021.
- Jeff Yass's portfolio value fell 11% quarter-over-quarter to $667B.
Based on Susquehanna International Group's 13F filing for Q4 2021, filed 14 Feb 2022.